TCRvβ8 chimeric antigen receptor natural killer cells exhibit potent preclinical activity against T-cell malignancies

Clin Transl Med. 2024 Aug;14(8):e70004. doi: 10.1002/ctm2.70004.

Lianjun He^{1

2}, Yinmei He³, Ye He⁴, Xing Bao¹, Yuqiong Yang⁵, Xueyi Qian^{1

2}, Ziyun Lin⁶, Weijie He¹, Yao Wu¹, Huimin Shao¹, Lingjie Zhou¹, Lin Wan⁶, Zhenyu Xu^{1

2}

¹ Precision Medicine Centre, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, China.
² School of Pharmacy, Wannan Medical College, Wuhu, China.
³ Department of Pharmacy, The Second Affiliated Hospital of Wannan Medical College, Wuhu, China.
⁴ Department of Radiotherapy, The Second People's Hospital of Wuhu City, Wuhu, China.
⁵ Department of Hematology, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, China.
⁶ Department of Pediatrics, The First Affiliated Hospital of Shandong First Medical Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China.

No abstract available

Publication types